Isis Cholesterol Drug Shown Effective
13th Nov 2006, 16:41 GMT
Isis Pharmaceuticals said data from 2 mid-stage clinical trials showed its cholesterol-lowering drug was safe and effective in reducing LDL, or bad, cholesterol.
Isis Cholesterol Drug Shown Effective related news:
- Isis Says New Drug Effective Against Cholesterol — RedOrbit News - Health
- Isis Pharma's shares soar on cholesterol-drug Phase II data — MarketWatch.com - Top Stories – Sponsored by: CyberTrader
- Positive Results for Anti-Cholesterol Drug — NYT > Business
- Isis Soars on Cholesterol-Drug News — BusinessWeek Online --
- Drug stocks pare gains; Solexa, Isis shares soar — MarketWatch.com - Top Stories – Sponsored by: CyberTrader
- A Big Drug From A Small Biotech — Forbes.com Business News
- FAME: Pharmacy-Care Program Improves Medication Adherence, as Well as BP and LDL-Cholesterol Levels — Medscape Cardiology Headlines
- Cholesterol Screening A Cost-effective Procedure To Extend Life In Hodgkin's Disease Survivors — Health News from Medical News Today
- - Webcast Alert: Isis Pharmaceuticals Announces Its Analyst/Investor Webcast Presentation — Partnerships/ Joint Ventures News from StratCenter.com
- Bristol arthritis drug effective in children: study — Reuters: Health
Latest news from Pharmaceuticals News from StratCenter.com:
- Spectrum Pharmaceuticals to Receive $5 mln Milestone Payment From PAR Pharmaceutical for Sumatriptan Injection
- Medco to Present at the Credit Suisse Annual Healthcare Conference
- Bob Dole Medicare Podcast Helps Seniors through 2007 Drug Coverage Enrollment Process
- Unique Sugar Improves Energy, Pain and Quality of Life in Fibromyalgia and Chronic Fatigue Patients!
- Care Clinic Purchases Pinnacle Easy Care
- Pegasystems Enhances 2 Business Critical BPM Frameworks for the Healthcare Industry
- Taro Receives Marketing Authorization in UK for Etopan XL Tablets 600 mg, Etodolac
- Nymox Reports Q3 2006 Financial Results
- RemoteMDx Raises $6 mln in Private Placement
- Akorn, FDC Team Up for Eye Drugs